World Pharma News Digest - 13.01.2014
3 views
Skip to first unread message
Ruslan David
Jan 13, 2014, 5:04:22 AM1/13/14
to worldph...@googlegroups.com
Researchers develop artificial bone marrow
Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tübingen University (Germany). The porous structure possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells at the laboratory. This might facilitate the treatment of leukemia in a few years.
Read more...
http://www.worldpharmanews.com/research/2668-researchers-develop-artificial-bone-marrow
Antipsychotic drug exhibits cancer-fighting properties
In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL). The drug works by turning on a cancer-suppressing enzyme called PP2A and causing malignant tumor cells to self-destruct.
Read more...
http://www.worldpharmanews.com/research/2667-antipsychotic-drug-exhibits-cancer-fighting-properties
MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an oncology research collaboration and licensing agreement with Immunocore Limited, a privately-held, UK-based biotechnology company. Both companies will research and develop novel cancer therapies using Immunocore's Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology.
Read more...
http://www.worldpharmanews.com/astrazeneca/2666-medimmune-and-immunocore-enter-immunotherapy-agreement-to-develop-novel-cancer-therapies
Study finds that information is as important as medication in reducing migraine pain
The information that clinicians provide to patients when prescribing treatments has long been thought to play a role in the way that patients respond to drug therapies. Now an innovative study of migraine headache confirms that a patient's expectations - positive, negative or neutral - influence the effects of both a medication and a placebo.
Read more...
http://www.worldpharmanews.com/research/2665-study-finds-that-information-is-as-important-as-medication-in-reducing-migraine-pain
Bayer and Peking University establish new research center for translational research and drug discovery in Beijing
Bayer HealthCare and Peking University (PKU), Beijing, China, have signed a comprehensive collaboration agreement on a three-year strategic partnership to promote translational research for drug discovery. Under this agreement, the two partners will establish a joint research center at Peking University under the name Bayer HealthCare/Peking University Center of Translational Research for Drug Discovery (BPC/TRDD).
Read more...
http://www.worldpharmanews.com/bayer/2664-bayer-and-peking-university-establish-new-research-center-for-translational-research-and-drug-discovery-in-beijing
New technique targets specific areas of cancer cells with different drugs
Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was developed by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.
Read more...
http://www.worldpharmanews.com/research/2663-new-technique-targets-specific-areas-of-cancer-cells-with-different-drugs
GSK adds detailed clinical trial data to multi-sponsor request system
GlaxoSmithKline (GSK) has added its anonymised patient-level data from the online request system it launched in May 2013 to a new multi-sponsor request system that includes studies from multiple organisations.
Read more...
http://www.worldpharmanews.com/gsk/2662-gsk-adds-detailed-clinical-trial-data-to-multi-sponsor-request-system
PharmaNews.eu / Latest News
Research uncovers key difference between our bodies' fight against viruses and bacteria
http://www.pharmanews.eu/research-and-development/1386-research-uncovers-key-difference-between-our-bodies-fight-against-viruses-and-bacteria
New clues to how bacteria evade antibiotics
http://www.pharmanews.eu/research-and-development/1384-new-clues-to-how-bacteria-evade-antibiotics
Cancer drug protects against diabetes
http://www.pharmanews.eu/research-and-development/1383-cancer-drug-protects-against-diabetes
Marine bacteria to fight tough infections
http://www.pharmanews.eu/research-and-development/1385-marine-bacteria-to-fight-tough-infections
Genetic variants linked with schizophrenia have impact in healthy carriers
http://www.pharmanews.eu/research-and-development/1382-genetic-variants-linked-with-schizophrenia-have-impact-in-healthy-carriers
University of East Anglia scientists make major advances important for cancer research
http://www.pharmanews.eu/research-and-development/1381-university-of-east-anglia-scientists-make-major-advances-important-for-cancer-research
Research into fruit fly cells could lead to cancer insights
http://www.pharmanews.eu/conferences-and-events/1380-research-into-fruit-fly-cells-could-lead-to-cancer-insights
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please download World Pharma News' Media Pack: http://www.worldpharmanews.com/contact-us
Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tübingen University (Germany). The porous structure possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells at the laboratory. This might facilitate the treatment of leukemia in a few years.
Read more...
http://www.worldpharmanews.com/research/2668-researchers-develop-artificial-bone-marrow
Antipsychotic drug exhibits cancer-fighting properties
In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL). The drug works by turning on a cancer-suppressing enzyme called PP2A and causing malignant tumor cells to self-destruct.
Read more...
http://www.worldpharmanews.com/research/2667-antipsychotic-drug-exhibits-cancer-fighting-properties
MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into an oncology research collaboration and licensing agreement with Immunocore Limited, a privately-held, UK-based biotechnology company. Both companies will research and develop novel cancer therapies using Immunocore's Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology.
Read more...
http://www.worldpharmanews.com/astrazeneca/2666-medimmune-and-immunocore-enter-immunotherapy-agreement-to-develop-novel-cancer-therapies
Study finds that information is as important as medication in reducing migraine pain
The information that clinicians provide to patients when prescribing treatments has long been thought to play a role in the way that patients respond to drug therapies. Now an innovative study of migraine headache confirms that a patient's expectations - positive, negative or neutral - influence the effects of both a medication and a placebo.
Read more...
http://www.worldpharmanews.com/research/2665-study-finds-that-information-is-as-important-as-medication-in-reducing-migraine-pain
Bayer and Peking University establish new research center for translational research and drug discovery in Beijing
Bayer HealthCare and Peking University (PKU), Beijing, China, have signed a comprehensive collaboration agreement on a three-year strategic partnership to promote translational research for drug discovery. Under this agreement, the two partners will establish a joint research center at Peking University under the name Bayer HealthCare/Peking University Center of Translational Research for Drug Discovery (BPC/TRDD).
Read more...
http://www.worldpharmanews.com/bayer/2664-bayer-and-peking-university-establish-new-research-center-for-translational-research-and-drug-discovery-in-beijing
New technique targets specific areas of cancer cells with different drugs
Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was developed by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.
Read more...
http://www.worldpharmanews.com/research/2663-new-technique-targets-specific-areas-of-cancer-cells-with-different-drugs
GSK adds detailed clinical trial data to multi-sponsor request system
GlaxoSmithKline (GSK) has added its anonymised patient-level data from the online request system it launched in May 2013 to a new multi-sponsor request system that includes studies from multiple organisations.
Read more...
http://www.worldpharmanews.com/gsk/2662-gsk-adds-detailed-clinical-trial-data-to-multi-sponsor-request-system
PharmaNews.eu / Latest News
Research uncovers key difference between our bodies' fight against viruses and bacteria
http://www.pharmanews.eu/research-and-development/1386-research-uncovers-key-difference-between-our-bodies-fight-against-viruses-and-bacteria
New clues to how bacteria evade antibiotics
http://www.pharmanews.eu/research-and-development/1384-new-clues-to-how-bacteria-evade-antibiotics
Cancer drug protects against diabetes
http://www.pharmanews.eu/research-and-development/1383-cancer-drug-protects-against-diabetes
Marine bacteria to fight tough infections
http://www.pharmanews.eu/research-and-development/1385-marine-bacteria-to-fight-tough-infections
Genetic variants linked with schizophrenia have impact in healthy carriers
http://www.pharmanews.eu/research-and-development/1382-genetic-variants-linked-with-schizophrenia-have-impact-in-healthy-carriers
University of East Anglia scientists make major advances important for cancer research
http://www.pharmanews.eu/research-and-development/1381-university-of-east-anglia-scientists-make-major-advances-important-for-cancer-research
Research into fruit fly cells could lead to cancer insights
http://www.pharmanews.eu/conferences-and-events/1380-research-into-fruit-fly-cells-could-lead-to-cancer-insights
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please download World Pharma News' Media Pack: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages